To improve medical treatment, researchers test new drug ingredients on biological cells. By combining two microscopy techniques, the time required for testing can be reduced by 50 to 80 percent.
And far fewer measurements are needed.
When developing new medications, biologists and pharma- cologists test different active ingredients and chemical compounds. The main purpose is to find out how biological cells react to these substances. To do so, researchers often use a fluorescence microscope that produces digital, holo- graphic images, i.e. computer-generated holograms in which the cells being studied can be viewed in three dimen- sions. The hologram is first created as an optical image, which is then digitized for recording and analysis on the computer. The computer calculates the data needed to display the three-dimensional image of the cells. This method has several advantages. The researchers don’t have to use markers to make the cells visible. They can examine the cells without touching them. And the cells can be characterized in vivo – scientists refer to this as in vivo testing.
To obtain precise and reliable answers to the question of how the cells react to chemical substances, each cell must be placed in an individual, tiny hollow (well) on a microfluidic chip, i.e. one cell per well. This ensures that the cells are not influenced by the presence of other cells. Another requirement is that the cells must be of the same size, so that their reactions to the active agent can be compared. The problem is that it is difficult to transfer single cells to the tiny wells. Often, the researchers pour them in together with the nutrient solution in which they were grown. This can have two unwanted consequences: firstly that several cells occupy the same well and secondly that the cells are of all different sizes. It can even happen that cells swim out of the wells during the test. The researchers have to take all these factors into account by employing statistical averaging. In other words they have to carry out innumerable measurements and test large numbers of cells in order to obtain a scientifically accurate result – an undertaking that can be extremely tedious and time-consuming.
Combination of digital holographic microscopy and optical tweezers
Researchers at the Fraunhofer Institute for Production Technology IPT in Aachen have found a solution to this problem. “It combines digital holographic microscopy with the use of optical tweezers,” reveals IPT group manager Stephan Stürwald. Optical tweezers are a special instrument that uses the force of a focused laser beam to trap and move micro- scopic objects. This tool enables the researchers to pick up selected cells, transfer them to individual wells of a microarray, and keep them trapped there. “By combining these two instruments, we can save between 50 and 80 percent of the time normally needed for such work, depending on the type of cell and the test method employed. That’s mainly because we don’t have to carry out so many repeated measurements,” explains Stürwald. The system is very easy to use, and the optical tweezers can also be controlled via the touchscreen of a tablet PC.
The combination of these two techniques not only simplifies current test procedures but also allows new tests to be developed. For instance, it is possible to position cells at a defined distance from one another, thus creating different patterns. In this way, the scien- tists will be able to observe cell interactions, because the spacing between them is ident- ical and fixed. One possible application is in the study of apoptosis, or sudden cell death. When a cell dies by apoptosis, it excretes substances that affect the behavior of other cells around it. But within what radius? Researchers will now be able to directly answer this question. The new system will also enable them to use the laser to selectively destroy cells that that are unsuitable for testing. A prototype of the system has already been built. It con- sists of two modules: the optical tweezers and the digital holographic microscope. The researchers have successfully carried out initial tests using the new system.
The Latest on: Testing of new pharmaceuticals
via Google News
The Latest on: Testing of new pharmaceuticals
- Cancer Prevention Pharmaceuticals Submits New Drug Application to the FDA for CPP-1X/sul for Treatment of Familial Adenomatous Polyposison June 29, 2020 at 5:00 am
FAP is a rare genetic disease that if left untreated progresses to colorectal cancer in nearly 100% of patients. The clinical development of CPP-1X/sul was designed to establish this fixed dose ...
- CEO Of Roche Pharmaceuticals On Serving Patients During The Pandemic And Driving Transformational Changeon June 29, 2020 at 3:08 am
I started asking people what they thought the challenges were, they told me they loved the mission-centered on patients, the focus on great science, and supportive culture. But I also heard from ...
- Bayer to test new drugs on 3D-printed heart tissue at Tel Aviv Universityon June 29, 2020 at 1:19 am
The new method of testing on 3D printed hearts bypasses many tedious screening methods, making it faster, cheaper, and more efficient.
- Burning Rock and CStone Pharmaceuticals reached a strategic collaboration on the co-development of companion diagnostics for pralsetinib in Chinaon June 28, 2020 at 6:23 pm
On June 29, 2020, Burning Rock Biotech Limited (NASDAQ: BNR) announced a strategic partnership with CStone Pharmaceuticals (HKEX: 2616) to co-develop and commercialize companion diagnostics (CDx) for ...
- New Pharma ETF Focuses on Testing and Treatment for Infectious Diseases--but Not Covid-19on June 28, 2020 at 1:51 pm
GERM offers investors exposure to established providers and ‘unsung heroes’ of biotech and life sciences Continue ...
- German Drugmaker Bayer To Test New Drugs With 3D-Printed Heart Tissues At TAUon June 28, 2020 at 6:51 am
As part of the agreement, Dvir's lab and Bayer will aim to test new cardiology medication for toxicity and efficacy ...
- Pulling the Levers of Stability Testingon June 26, 2020 at 2:46 am
The ICH pharmaceutical stability guidelines have been implemented ... EMA, ICH Topic Q1A(R2): Stability Testing of New Drug Substances and Products, ema.europa.eu, Guidance Document (August 2003).
- Digital Pregnancy Test Kit Market : Exploring Opportunities and CAGR of 4% Forecast Till 2028on June 26, 2020 at 1:33 am
The Digital Pregnancy Test Kit market size is projected to expand from USD 178.3 Mn in 2018 to USD 263.9 Mn by 2028, at a Compound Annual Growth Rate (CAGR) of 4% during the forecast period. (Note: ...
- The Hill's Coronavirus Report: Tulsa County reports highest number of new cases days before Trump rally; Botanisol Analytics CEO David Talenfeld says new highly mobile virus ...on June 18, 2020 at 12:25 pm
Reversing course, Arizona and Texas will allow some local governments to require masks | Nearly 90 percent of Americans think pharmaceutical industry will use pandemic to raise drug prices | Tulsa ...
- Testing for Nitrosamines in Pharmaceutical Drugson June 2, 2020 at 5:00 pm
The current most common methods for testing small-molecule pharmaceutical products are gas chromatography–mass spectrometry (GC–MS), liquid chromatography (LC)–MS/MS or high resolution (HR) LC–HRMS.
via Bing News